
STOK vs PCRX
$STOK vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
STOK vs PCRX: the quick read
- ·STOK is the larger company by market cap ($1.45B vs $1.45B).
- ·PCRX has been more active on our scanner (73 vs 66 alerts in 30 days).
- ·PCRX has the smaller float (34.1M vs 56.2M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 73 and 66 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: PCRX is near the top of its 52-week range while STOK is near the bottom of its own.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing STOK and PCRX on TheDesperateTrader.
- Is STOK or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. STOK is the larger company by market cap ($1.45B vs $1.45B). PCRX has been more active on our scanner (73 vs 66 alerts in 30 days). PCRX has the smaller float (34.1M vs 56.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between STOK and PCRX?
- The differences that matter: they are similar in size ($1.45B vs $1.45B); they trade at very different share prices ($22.50 vs $36.32); STOK sits at 11% of its 52-week range against 99% for PCRX; our scanner flagged STOK 66 times in the last 30 days against 73 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of STOK and PCRX is more active right now?
- Right now STOK is at about 0.7x its normal volume and PCRX is at about 1.3x, so PCRX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading STOK or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.